Research Resources Initiative by the NFRP
The NFRP now offers a service on our website featuring a listing of available NF research resources!! Our goal is to facilitate and speed NF research by publicizing new resources and aiding collaborations. The list displays available resources and repository or PI contact information. Please contact the repository or PI directly for information and requests.
| Award Number | PI | Product or Resource | References | Contact Information or Link |
| Mouse Models | ||||
|---|---|---|---|---|
|
Nancy Ratner |
PlpCre;Nf1 flox/flox |
Mayes D.A., Rizvi T, Canselas J, et al. 2011 Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation. Cancer Research 71(13):1-11. |
Please contact both Drs. Nancy Ratner (nancy.ratner@cchmc.org) and Luis Parada (luis.parada@utsouthwestern.edu). |
|
|
Florent Elefteriou |
Nf1 loss of function in chondrocytes |
Wang W, et al. 2011. Mice lacking Nf1 in osteochondroprogenitor cells displays skeletal dysplasia similar to patients with neurofibromatosis type 1. Human Molecular Genetics 20(20):3910-3924. |
||
|
Feng-Chun Yang |
NF1 skeletal model with reduced bone mineral density, reduced calcium ossification, reduced bone turnover, and increased ratio of spinal canal area to vertebral body area |
Xiaohua W, et al. 2011. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis Type 1. Public Library of Science 6(9):e24917. |
||
|
Andrea McClatchey |
Model of renal carcinoma: Vil-Cre; Nf2lox/lox |
Morris ZS and McClatchey AI. 2009. Aberrant epithelial morphology and persistent EGFR signaling in a mouse model of renal cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America 106(24):976-982. |
||
|
Tyler Jacks |
Paternal inheritance of Nestin-Cre resulting in mosaic loss of Nf2: NesCreP; Nf2flox/flox |
McLaughlin ME et al. 2007. The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion. Proceedings of the National Academy of Sciences of the United States of America 104(9):3261-3266. |
||
|
Kevin Shannon |
Model of myeloproliferative disorder: Mx1-Cre; Nf1flox/flox |
Le DT et al. 2004. Somatic inactivation of NF1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 103(11):4243-4250. |
||
|
Marco Giovannini |
|
|
||
|
Luis Parada |
Conditional knockout of Nf1: Nf1 flox/flox |
Zhu Y et al. 2001. Ablation of NF1 function in neurons induces abnormal brain development of cerebral cortex and reactive gliosis in the brain. Genes & Development 15(7):859-876. |
http://mouse.ncifcrf.gov/available_details.asp?ID=01XM4 (external link) |
|
|
Luis Parada |
Nf1+/-; p53+/- cis |
Cichowski K et al. 1999. Mouse models of tumor development in neurofibromatosis type 1. Science 286(5447):2172-2176. |
http://jaxmice.jax.org/strain/008191.html (external link) |
|
|
Tyler Jacks |
Nf1+/-; p53+/- cis |
Vogel KS et al. 1999. Mouse tumor model for neurofibromatosis type 1. Science 286(5447):2176-2179. |
http://jaxmice.jax.org/strain/008191.html (external link) |
|
|
Tyler Jacks |
Model of glioblastoma: Nf1 +/-; Trp53 +/- |
Reilly KM et al. 2000. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nature Genetics 26(1):109-113. |
||
|
Tyler Jacks |
Nf2 +/-; p53 +/- |
McClatchey AI et al. 1998. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes & Development 12(8):1121-1133. |
||













